Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Z Alourfi x
  • Refine by access: All content x
Clear All Modify Search
Z Alourfi ARC Epidemiology Unit,
Endocrine Sciences Research Group, and
Centre for Molecular Medicine, Faculty of Medicine, University of Manchester, Manchester M13 9PT, UK

Search for other papers by Z Alourfi in
Google Scholar
PubMed
Close
,
R P Donn ARC Epidemiology Unit,
Endocrine Sciences Research Group, and
Centre for Molecular Medicine, Faculty of Medicine, University of Manchester, Manchester M13 9PT, UK

Search for other papers by R P Donn in
Google Scholar
PubMed
Close
,
A Stevens ARC Epidemiology Unit,
Endocrine Sciences Research Group, and
Centre for Molecular Medicine, Faculty of Medicine, University of Manchester, Manchester M13 9PT, UK

Search for other papers by A Stevens in
Google Scholar
PubMed
Close
,
A Berry ARC Epidemiology Unit,
Endocrine Sciences Research Group, and
Centre for Molecular Medicine, Faculty of Medicine, University of Manchester, Manchester M13 9PT, UK

Search for other papers by A Berry in
Google Scholar
PubMed
Close
,
A McMaster ARC Epidemiology Unit,
Endocrine Sciences Research Group, and
Centre for Molecular Medicine, Faculty of Medicine, University of Manchester, Manchester M13 9PT, UK

Search for other papers by A McMaster in
Google Scholar
PubMed
Close
, and
D W Ray ARC Epidemiology Unit,
Endocrine Sciences Research Group, and
Centre for Molecular Medicine, Faculty of Medicine, University of Manchester, Manchester M13 9PT, UK

Search for other papers by D W Ray in
Google Scholar
PubMed
Close

MIF is a potent proinflammatory cytokine involved in inflammatory arthritis. Glucocorticoids (GC) have been reported to induce secretion of MIF in rodent cells, and as MIF counteracts the anti-inflammatory effects of GC, this has implications for human inflammatory disease. Transient transfection studies showed that the MIF promoter was repressed by dexamethasone (Dex) (10 nM) in CEM C7A cells, with up to 50% suppression by 100 nM. However, there was no regulation of the promoter by GC in A549 cells. We also found that subnanomolar concentrations of Dex suppressed MIF secretion, measured by ELISA, by 80% in both human T lymphoblasts (CEM C7A) and human lung epithelial cells (A549). Endogenous MIF mRNA was also repressed by GC in CEM C7A cells, measured both by Northern blot and quantitative RT-PCR assays, but there was no such regulation in A549 cells. This suggests that GC affects translation rather than transcription of MIF in A549 cells. These results contradict earlier results with the rat cell line RAW 264.7. Therefore, we analysed MIF secretion from RAW 264.7 cells but found no GC effect on secretion. Understanding how GC regulates MIF in a cell-type-dependent manner may give insights into GC-refractory human inflammatory diseases.

Free access